A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.

NCT00270062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: epoetin alfa

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.